Medicare limits access to lifesaving treatments for common illnesses, including a type of heart valve disease affecting 2.5 ...
New research shows GLP-1 drugs may cut heart failure and cardiovascular risks in high‑risk patients, even as Medicare delays a pilot program to expand coverage for weight‑loss use. Observational ...
New studies suggest GLP-1 receptor agonists, including tirzepatide, reduce heart failure and other risks in patients undergoing procedures like TAVR and CAS, expanding their cardiovascular profile.
After months of dizziness and arms aching so badly she could barely walk her dog, Susan Glannan lay stunned in a sunny hospital room as a doctor told her she should have open heart surgery. The idea ...
New research found that public interest in Transcatheter Aortic Valve Replacement (TAVR) increased substantially over the ...
New research found that public interest in Transcatheter Aortic Valve Replacement (TAVR) increased substantially over the last decade, with Google search volume rising by 340% from 2015 to 2025, while ...
New research found that public interest in Transcatheter Aortic Valve Replacement (TAVR) increased substantially over the ...
FRESNO, Calif. (KFSN) -- The City of Fresno is now offering money to upgrade damaged and potentially dangerous properties. The Mobile Home Replacement Program is now available to residents, expanding ...
When John Cantrell retired, he decided his new job would be staying healthy. He was already in good shape and ate well but he wanted to make sure he could see his grandkids grow up. Already an avid ...
Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable outcomes regardless of whether they underwent percutaneous coronary intervention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results